Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The entry "zinc finger, MYM-type 1 pseudogene" (ENSG00000275508) refers to a pseudogene associated with the zinc finger, MYM-type protein family, but not an active protein-coding gene. "Zinc finger MYM-type 1 pseudogene" (ENSG00000275508) is annotated as a pseudogene, meaning it is a DNA sequence related to the functional gene ZMYM1 (Zinc finger MYM-type containing 1), but is not believed to encode a functional protein. Pseudogenes generally do not produce active proteins and are not known to have direct biological roles, nor are they drug targets[1][4]. Key context and supporting detail: - The ZMYM1 gene encodes a protein of the zinc finger MYM-type family, which are typically involved in zinc ion binding, protein dimerization, and usually function in the nucleus[1]. - However, the suffix "pseudogene" and the specific Ensembl ID ENSG00000275508 indicate this entry is not an active gene but a non-coding, non-functional remnant[1]. - There are no current data implicating this pseudogene as a drug target or as having any direct role in disease or cellular function[1][4]. - Zinc finger protein families (such as MYM-type) are otherwise known for DNA/RNA binding, transcriptional regulation, and various biological processes when functional, but these attributes do not apply to pseudogenes[4]. If you are seeking information about the functional gene, search for ZMYM1 (Zinc finger MYM-type containing 1), ENSG00000197056[1]. Summary of limitations: The current entry is a *pseudogene*, not a functional molecular target, and therefore does not meet criteria for drug targeting, mechanism of action, or biomarker status. There is no evidence or literature supporting its use or importance as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger MYM-type 1 pseudogene.